Clinical Trial Detail

NCT ID NCT02038699
Title A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors Oncoceutics, Inc.
Indications

non-small cell lung carcinoma

Her2-receptor negative breast cancer

colorectal cancer

glioblastoma multiforme

Therapies

ONC201

Age Groups: adult

Additional content available in CKB BOOST